ReviewBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
Corynebacterium pseudodiphtheriticum as etiologic agent of human infections worldwide: a review of case reports within the last 40 years (1983-2023).
Review in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Corynebacterium pseudodiphtheriticum has been increasingly reported as an etiologic agent of both community-acquired and nosocomial infections, despite its common presence as a harmless member of the human upper respiratory tract and skin microbiota. However, infections caused by C. pseudodiphtheriticum and other corynebacterial species are still frequently misclassified as contamination and overlooked during clinical and laboratory diagnoses in several countries. In this study, an extensive review of human infections and nosocomial outbreaks caused by C. pseudodiphtheriticum was conducted through the analysis of reported cases from various countries, over a 40-year period (1983-2023). This review highlights the dichotomous nature of C. pseudodiphtheriticum, emphasizing both its potential biotechnological applications and its role as a human pathobiont affecting immunocompromised and immunocompetent individuals worldwide. Therefore, this study supports the inclusion of C. pseudodiphtheriticum in the list of clinically relevant pathogens and underscores the need for research into the virulence mechanisms involved in its pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.